The International Federation of Pharmaceutical Manufacturers and Associations has issued a call for greater cooperation and integration of efforts to counter "neglected" tropical diseases, to coincide with the first World Health Organization Global Partners Meeting on Neglected Tropical Diseases in April.
Harvey Bale, the IFPMA's director general, said: "worldwide, one in six people suffers from one or more of these tropical diseases. This is a global issue and we need to work out global solutions. There is a growing body of NTD experience to be shared, much of which has been generated in partnerships involving the pharmaceutical industry, to improve access to existing treatments, to research new ones and to develop them into useable medicines."
Dr Bale added that he welcomed "the WHO's efforts to improve the existing approaches involving intergovernmental organizations, national governments, non-governmental organizations and the drug industry."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze